SENORES — Senores Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Senores Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	32.1	1	131	3,855	3,323
Net Total Accounts Receivable
Net Total Receivables	207	402	1,927	2,701	3,248
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	271	513	2,509	7,224	8,124
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	61.2	153	1,791	2,524	3,627
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	592	1,311	6,219	12,269	16,038
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	98.8	519	2,475	2,407	4,240
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	226	856	4,176	4,407	6,702
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	366	455	2,043	7,862	9,336
Total Liabilities & Shareholders' Equity	592	1,311	6,219	12,269	16,038
Total Common Shares Outstanding